Clinical Trials Directory

Trials / Unknown

UnknownNCT04436224

Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation

Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation: A Dose-exploration and Effectiveness Study

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
530 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hydromorphone has a clear analgesic effect, and has few advantages in respiratory depression and gastrointestinal motility. The study will further explore the continuous pumping-dose of hydromorphone for ICU non-mechanical ventilation patients and monitor its effective plasma concentration as well as evaluates the safety and effectiveness of hydromorphone for ICU non-mechanical ventilation patients.

Conditions

Interventions

TypeNameDescription
DRUGHydromorphoneIntravenous analgesia using hydromorphone in ICU patients with non-mechanical ventilation(NS 40ML+ hydromorphone 10mg ,IV-Pump)
DRUGFentanylIntravenous analgesia using fentanyl in ICU patients with non-mechanical ventilation(NS 40ML+ fentanyl 0.5mg, IV-Pump)
DRUGButorphanolIntravenous analgesia using butorphanol in ICU patients with non-mechanical ventilation(NS 40ML+ butorphanol 10mg,IV-Pump)

Timeline

Start date
2020-09-04
Primary completion
2022-06-01
Completion
2022-09-01
First posted
2020-06-17
Last updated
2022-01-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04436224. Inclusion in this directory is not an endorsement.